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Technical Review of Endovenous Laser Therapy for Varicose Veins
R.R. van den Bos, M.A. Kockaert, H.A.M. Neumann and T. Nijsten*
Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
Background. In the last decade, several new treatments of truncal varicose veins have been introduced. Of these new ther-
apies, endovenous laser therapy (EVLT) is one of the most widely accepted and used treatment options for incompetent
greater and lesser saphenous veins.
Objective. The objective of this report is to inform clinicians about the EVLT procedure and to review its efficacy and
safety in treatment of truncal varicose veins. Also, we discuss some of the underlying theoretical principles and laser pa-
rameters that affect EVLT.
Methods. We carried out a literature review of EVLT‘s efficacy and safety. We included reports that included 100 or more
limbs with a follow-up of at least 3 months. The principals and procedure of EVLT are described. Of the laser parameters,
mode of administration, wavelength, fluence, wattage and pullback speed are discussed.
Conclusion. EVLT appears to be a very effective and safe option in the treatment of varicose veins but large randomized
comparative studies are needed.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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The treatment of varicose veins reduces the symptoms
and the complication rate of venous insufficiency and
increases the patient’s health related quality of life
(HRQOL). The classic surgical strategy for incompe-
tence of the great saphenous vein (GSV) is a high liga-
tion and stripping at the saphenofemoral junction
(SFJ). Venous insufficiency of the lesser saphenous
vein (LSV) is conventionally treated by ligation (and
stripping) at the saphenopopliteal junction (SPJ).
However, recurrence occurs in approximately one
third of cases after 5 years.1,2 Other disadvantages in-
clude the necessity of general anaesthesia and the de-
velopment of scars and post-operative pain. Adverse
events associated with venous stripping are wound
infection and saphenous nerve injury. To improve
efficiency, HRQOL and to reduce serious side effects,
costs and post-operative pain, new minimally inva-
sive techniques, such as ultrasound-guided foam
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(VNUS closure) and endovenous laser therapy
(EVLT) have been introduced.3 Although UGFS, RFA
and EVLT are likely to fulfil these criteria and will
play a prominent role in the treatment of varicose
veins in the future, no controlled trials of the three
major treatment options have been reported yet. The
objective of this review is to inform physicians about
EVLT from a practical (i.e. EVLT procedure) and tech-
nical (i.e., laser parameters) perspective.
Methods
A literature review of EVLT’s efficacy and safety was
performed. We carried out an electronic search of
Medline, Cochrane library and Cinahl. We searched
Pubmed with the following algorithm: (laser OR laser
surgery) AND (saphenous OR saphena OR varicose
veins OR varicosis OR endovascular OR endovenous)
AND (duplex OR doppler OR ultrasonic OR ultra-
sound). We checked titles and abstracts of the
retrieved articles (n¼ 237). To broaden the search we
used the ‘‘related articles’’ function. In the evaluation
of efficacy and safety, we included reports thatn behalf of European Society for Vascular Surgery.
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least 3 months. The mechanism and procedure of
EVLT are described. Of the laser parameters, mode
of administration, wavelength, fluence, wattage and
pullback speed are discussed.
Indications for EVLT
The most common indication for EVLT is an insuffi-
cient GSV and to a lesser extent LSV (with or without
insufficiency of junction) demonstrated by US exami-
nation and/or clinical presentation (‘Clinical’ stage 2
to 6 of the CEAP classification). In addition to primary
truncal varicosities, accessory and perforator veins,
recurrent truncal varicosities, varicosities in patients
with postthrombotic or Klippel-Trenaunay syndrome
and congenital venous malformations have been
treated successfully with EVLT.4e7
Practical description of Endovenous Laser Therapy
EVLT can be performed under local tumescent anaes-
thesia in an outpatient setting. The EVLT procedure
varies between centres and we will describe it as
reported by Navarro.8 Venous access is obtained by
a needle puncture (incision is rarely needed) under
US guidance (Fig. 1). Most commonly, the insufficient
GSV is entered at knee level because of its large diam-
eter, linear course and the smaller risk of nerve injury.
If possible, identified causes of venous insufficiency,
such as paratibial perforator (Boyd’s perforator),
should be treated concurrently. The treated length of
the LSV is usually relatively short (5e20 cm) but an
insufficient May’s perforator should be included.
Stimulation of the varicose vein with the needle may
Fig. 1. Access to the vein is obtained by a needle puncture
under US guidance.result into local venous spasm, but the vein can be
re-punctured about 10 cm proximal of the original
site. Otherwise, waiting, applying warm towels, re-
scheduling, or a surgical incision, are indicated. After
entrance to the varicose vein is established, a (metal)
guide wire is passed through the hollow needle into
the vein. If the varicose vein is tortuous, has a small
diameter (due to spasm), large branches, or contains
thrombotic or sclerotic fragments (after a phlebitis or
prior treatment, respectively), advancing the wire
can be difficult. Patients often report pain at the site
of obstruction and US may reveal the cause of ob-
struction. Re-introducing the wire, rotating the U-
shaped tip, local massage of the site, surgical incision
or intermittent treatment may be helpful, but should
be exercised with great caution because of the risk
of perforation and inducing embolic events.
After the guide wire is in place, the needle removed
and a small cutaneous incision of 3 mm is made, an
introducer sheath is passed over the guide wire. In
some disposable sets, the introducer sheath has a dila-
tor with a sharp point to increase rigidity and enhance
venous access. Subsequently, the guide wire (and dila-
tor) are removed when the sheath is at or beyond the
junction. Under longitudinal US visualization of the
junction, the echo dense tip of the sheath is pulled
back till it is located 1 to 2 cm distally from the junc-
tion (Fig. 2). This is the most pivotal step in the
EVLT procedure.
Subsequently, the laser with red stand-by light and
a diameter between 200e600 mm (dependent on the
varicose vein and the laser parameters) can be intro-
duced. Depending on the disposable set used, the
laser fibre should either be marked before insertion,
or will have fixed marks to indicate to what extent
the laser has to be advanced. In non-obese patients,
Fig. 2. The tip of the sheath is located 1 to 2 cm distal from
the crosse under US guidance.
90 R. R. van den Bos et al.position of the laser tip can be confirmed using the red
stand-by light of the laser that will be visible
transcutaneously.
Local tumescent anaesthesia (5 ml epinephrine,
5 ml bicarbonate and 35 ml 1% lidocaine diluted in
500 ml saline) is administered into the perivenous
space under US guidance either using a syringe or
pump. The needle tip is positioned near the varicose
vein and the tumescent, which will show as a black
mass, is injected under a cross sectional US image
(Fig. 3). The tumescent remains around the interfas-
cial part of the vein but will diffuse more at the extra-
fascial part. Therefore, more volume is required at this
part. Local tumescent anaesthesia has three functions:
(1) reduces pain, (2) protects perivenous tissue by
cooling and (3) increases surface area contact between
laser tip and vein wall.
Before activation of the laser, individuals in the
treatment room should wear protective laser goggles.
The parameters used, the velocity and technique in
which the laser is pulled back are variable and may
be laser dependent, they will be described extensively
in the following section.
Mechanisms of EVLT
Laser (Light Amplification by Stimulated Emission of
Radiation) creates high-energy, bundled light that is
monochromatic (one wavelength), collimated (pho-
tons run parallel) and coherent (in phase). The mech-
anism of EVLT is not entirely clear, but a thermal
reaction after laser exposure is likely to be essential.
The degree of heat induced cell destruction depends
on the temperature and duration of exposure. The
temperature of the laser tip increases to 800 C, direct
contact with the venous wall results in local destruc-
tion and may lead to (micro) perforation of the
Fig. 3. US image of tumescent anesthesia of varicose vein.Eur J Vasc Endovasc Surg Vol 35, January 2008vein.9 Venous compression by tumescent anaesthesia
increases contact surface area, which results in more
direct laser effects. The intravascular heat decreases
to 90 C at 4 mm of the laser tip due to absorption
by venous blood (deoxyhaemoglobin), which is dem-
onstrated by the observation that the penetration of
the 940 nm laser is 45 mm in water and 0.3 mm in
blood.10 In vitro and in vivo studies show that this in-
tense energy absorption results in ‘boiling of blood’
and the generation of ‘steam bubbles’ that indirectly,
but homogenously affect the varicose vein.11 The di-
rect and indirect thermal reactions induce scar forma-
tion, occlusion and finally absorption of the vein.
Histological studies show that EVLT damages the en-
dothelial and intimal layer, internal elastic lamina and
media to some degree. The adventitia is affected in
a minority of the treatments.12 In a pig model using
EVLT the peak temperature adjacent to the vessel is
rarely higher than 50 C, which is a minimum for
collagen degeneration.13
Laser parameters and their practical implications
The laser induced thermal reaction can be regulated to
some extend by adjusting several laser parameters
such as wavelength, type of administering laser
energy and the amount of energy per surface area
(fluence [J/cm2] or J/cm), which depends on wattage,
pulse duration and vessel surface area.
Pulsed and continuous wave
Using the pulsed mode, the blood vessel is exposed to
a fixed amount of energy at equal distances. The total
amount of administered energy depends on the dis-
tance between pulses (0.3e2 cm), pulse duration
(0.5e2 s) and energy (10e15 W). During continuous
mode, the laser is pulled back constantly and the total
energy delivered depends on pullback speed and
wattage. In most of the first EVLT studies pulsed
mode was used, but the majority of recent studies
use continuous mode. This is likely due to practical
considerations, such as standardization and duration
of treatment (8e10 vs. 1e3 min). Also, presentation
of total energy given per unit of length or area is
more difficult using pulsed mode and pulsed mode
is associated with a higher risk of adverse events
such as venous perforation.14
Wavelength and absorption spectra
Each chromophore (i.e., target such as haemoglobin or
water) has its own absorption spectrum (Fig. 4). The
91Technical EVLT Review810, 940 and 980 nm Diode lasers are used because
they are absorbed by deoxygenated haemoglobin
and the 980 nm also by water. The Nd:Yag lasers
(1320 nm) appears to be effective for EVLT.7,15,16 Two
comparative EVLT studies demonstrated that patients
treated with higher wavelengths reported less postop-
erative pain, used less painkillers and were less likely
to have ecchymosis.16,17
Fluence or Joule/cm
In laser therapy, fluence (J/cm2) is the single most
important parameter to quantify the amount of
energy given. The amount of Joules depends on the
wattage (J/s) and duration of treatment (pullback
speed or pulse duration in continuous and pulsed
wave, respectively). Because the surface area of the
venous wall (cm2) is difficult to estimate, most studies
report J/cm (or linear endovenous energy density) as
a surrogate marker of fluence. The length of the
varicose vein is estimated either by using a marked
catheter or by measuring the distance from the entry
site until 1e2 cm caudal of the junction. Proebstle
et al. have suggested the use of an endovenous fluence
equivalent taking the diameter of the vein into
consideration.18,19
Only very few of the initial EVLT studies reported
fluence or J/cm and it ranged between 20e40 J/cm.
In a multivariate analysis, Proebstle et al. demon-
strated that the amount of energy administered in
EVLTwas an independent predictor of GSV occlusion
rate.18 The same research group confirmed this in two
randomized clinical trials, which showed that 60 J/cm
was more effective than 25 J/cm16 and that an endo-
venous fluence equivalent of 20 J/cm2 (comparable
to about 60 J/cm) or more was associated with
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Fig. 4. Schematic absorption spectra of water (H2O) and
(deoxygenated) hemoglobin (Hb[O2]).durable GSV occlusion after 12 months.19 Another
study suggested that an energy dose greater than
80 J/cm resulted in a success rate of 100%.20 A math-
ematical model suggested that 65 and 100 J/cm was
needed for varicose veins of 3 and 5 mm respectively,
to destroy the intimae irreversibly.21
Wattage
Administering high wattage for a short time has a va-
porizing effect and low wattage for longer time has
a coagulating effect.12 Besides wattage, the amount
of energy also depends on the pullback speed and
pulse duration of the laser. Although using 10e15 W
is commonly accepted in EVLT, a recent randomized
study demonstrates that EVLT using 30 W (63 J/cm)
was more effective than 15 W (24 J/cm) with
a 940 nm Diode laser (100% vs. 90.3% occlusion after
3 months, respectively).16 However, a smaller case
series using a 980 nm laser suggested that 11 W was
as effective as 15 W, but was associated with fewer
side effects.22 It remains unclear whether these studies
show a true difference due to wattage (J/s) or whether
it is related to fluence (J/cm2).
Pullback speed
Using a pulsed mode, the pulse duration reflects the
exposure time. The pullback speed, however, is an im-
portant parameter in continuous mode. If the EVLT is
performed with fixed wattage, the energy given per
cm2 depends solely on the pullback speed and
can be reported as a function of the wattage (e.g.,
5 sec/cm). An alternative is that a laser display shows
the cumulative energy (J) administered while pulling
back, which enables the clinician to estimate the
amount of J/cm given up to a point.
Clinical Studies
Outcomes
Usually, the efficacy of EVLT is expressed in percent-
age of vessels occluded and/or the absence of flow on
US examination. Other studies have used the C of
CEAP classification (Clinical, Etiologic, Anatomic,
Pathofysiologic) or its derivative VCSS (Venous Clini-
cal Severity Score) as study endpoints.23 Also, changes
in the disturbed hemodynamics of varicose veins us-
ing venous fillings index24 and air plethysmography25
have been studied. In recent clinical trials, patient
reported outcomes such as HRQOL, satisfaction andEur J Vasc Endovasc Surg Vol 35, January 2008
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comparison of minimally invasive methods and
surgery.26,27
Case series
The first cohort studies suggesting EVLT is successful
in the treatment of large varicosities were published
in 2001.8,28 Thereafter, multiple case-series (number
of treated limbs ranging from 6 to 1250) have been
presented and a systematic review has been published
in 2005.29Table 1 presents a selection of EVLT studies
that include at least 100 limbs with at least 3 months
follow-up. A success rate of 100% one week after
EVLT is reported in most studies. Although success
rate decreases with time, it remains at least 90%. In
a prospective US study, 93% of 499 GSV were
occluded 2 years after therapy.30 An Italian work-
group reported a success rate of 97% in 1000 patients
with a follow-up of 3 years.26 Another large study
with more than 1250 limbs treated, showed a success
rate of approximately 95%.27 Some studies report
success rates lower than 90%, which may be due to
the characteristics of the varicose veins they treated
e.g. very large or tortous, or associated large insuffi-
cient perforator of Dodd or Hunter.5,31
Combined treatment studies
Because the management of varicose veins is usually
a combination of different types of interventions,
several studies have investigated the use of EVLT
combined with other therapies, such as ambulatory
phlebectomy,32 UGFS of the accessory vein and
smaller varices30 or UGFS and surgical stripping.33
Comparative studies
Three studies have compared EVLT with other treat-
ments of varicose veins. A small paired analysis of
20 patients showed one recanalization after EVLT
and none after junction ligation followed by a short
strip.25 Although no differences were noted in treat-
ment related pain, less swelling and bruising were
noted after EVLT compared to surgery. A retrospec-
tive study suggested that RFA and EVLTwere equally
effective, but three DVTwere reported after EVLT.34 A
nonrandomised pilot study compared EVLT (n¼ 70)
with inversed stripping of the GSV (n¼ 62).35 The
clinical efficacy parameters were comparable, but
EVLT had significant superior effect on the short
and long term HRQOL. Although cost-effectiveness
studies are lacking, EVLT is likely to reduce costsEur J Vasc Endovasc Surg Vol 35, January 2008because it has less down-time and is an outpatient
therapy.36
Adverse events
EVLT induces sclerosis and micro perforations of the
venous wall that often results in pain and ecchymo-
ses, which will disappear in one to two weeks, and
can be reduced by elastic stockings and pain killers.
The frequency and intensity of these symptoms may
be less for higher wavelengths and in continuous
than pulsed mode.16,37
Although minimally invasive techniques may re-
duce classical surgical side effects (e.g., wound infec-
tion and scarring), it may be associated with specific
adverse events such as DVT and skin burns (Table 1).
One day after EVLT, D-dimers were elevated in about
half of the patients and especially in those who had
a bilateral procedure.11 Due to the theoretical chance
of DVT, most studies carefully examined DVT inci-
dence after EVLT. Among three case series that in-
cluded 2750 limbs, only one lung emboli was
found.26,27,30 Two smaller studies detected several
EVLT induced DVTs (3/77 and 3/56), which may be
due to their retrospective design and/or is a reflection
of a learning curve.34,38 Proebstle reported on a patient
with polycythemia vera who developed a DVT after
EVLT.4 Some authors advise US examination one
week after EVLT to exclude DVT and others use
LMWH for 5e7 days post-operative.34 The incidence
of DVT seems to be at most comparable with surgical
treatment (about 2%). Low-risk patients do not need
thromboprophylaxis after treatment. Prophylaxis
with 20 mg enoxaparin did not guarantee against de-
veloping a DVT in ‘‘high-risk’’ patients either.39e41 Of
special concern in EVLT is the induction of emboli in
previously treated veins because inserting the sheaths
and fibres may induce detachment of thrombus.
Skin burns are another possible EVLT associated
adverse event and may occur if the administered en-
ergy is too high or the cooling effect of tumescent an-
aesthesia is insufficient. None of the major case series
reported skin burns and only a few smaller studies
reported superficial skin burns (Table 1).
A major disadvantage of stripping is the risk of
damaging the saphenous nerve (about 7% in short
to 40% in long stripping).5 As in surgery, the likeli-
hood of neurological damage is likely to be higher
in ‘long’ EVLT that start at ankle level than in ‘short’
EVLT procedures. Several other side effects of EVLT,
such as superficial thrombosis (5%),30 haematoma at
entry site (rare), cellulitis (especially with incisions
and less with needle punctures) and one case of an ar-
teriovenous fistula have been reported after EVLT.42
Duration of
follow-up
Complete
response
(partial)#
Major
complications
(No.)*
fficiency 2 years 93.4% (GSV) No
lcer: 8.9% 2 weeks 97.0% (all) No
C4: 47% 2 weeks 100% Skin burns (2)
3 months 90% No
3 months Average 98% No
sing
ficiency
1 year 76%$ (18%) Saphenous nerve
injury (1) Skin
burns (1)
C4: 46% 2 weeks and
200 for 1 year
96.7% (GSV)
91.0% (SSV)
Lung emboli (1)
C4e6: 8% 3 years 97% (all) No
mosis.
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2008Table 1. Characteristics of included Endovenous Laser Therapy (EVLT) studies
Author Year Type study Type laser (nm) No. of
limbs
Type (No.) of
varicose veins
Inclusion
Min et al. 2003 Prospective
case series
Diode (810 nm) 499 GSV (499) GSV and SFJ insu
on US
Perkowski et al. 2004 Prospective
case series
Diode (940 nm) 165 GSV (154) SSV (37)
Accessory vein (12)
C4 or more: 62% U
Huang et al.T 2004 Prospective
case series
Diode (810 nm) 230 GSV (230) C2: 37% C3: 11%
C5: 0.4% C6: 3.9%
Proebstle et al. 2004 Retrospective
case series
Diode (940 nm) 106 GSV (106) C2eC6@
Proebstle et al. 2005 RCT Diode (940) vs.
Nd:Yag (1320)
282 GSV (282) C2eC6@
Sharif et al. 2006 Prospective
case series
Diode (810 nm) 145 SSV (145) Primary and relap
isolated SSV insuf
Ravi et al. 2006 Prospective
case series
Diode (940 nm) 1091 GSV (990) SSV (101) C2: 29% C3: 11%
C5: 9% C6: 5%
Agus et al. 2006 Prospective
case series
Diode (810 &
980 nm)
1076 GSV (1052) SSV (16)
Accessory vein (8))
C2: 82% C3: 10%
# By US.
* Major complications: nerve injury, deep venous thrombosis ( emboli), and skin burns, but not pain and ecchy
T From ankle to groin and in 10 patients in combination with surgical approach.
@ C-classification not specified in number of patients.
$ Of 21 ‘failures‘: 12 passage of wire, 4 failed cannulation, 3 patient discomfort, 1 syncope, and 1 technical laser
94 R. R. van den Bos et al.Conclusion
About a decade after its introduction, EVLTappears to
be a very effective and safe option in the treatment of
varicose veins. Although thousands of patients
treated with EVLT with several years of follow-up
have been reported, no large randomized clinical tri-
als comparing EVLT with UGFS, RFA and surgery
have been performed yet. There is an urgent need
for comparative studies to assess long term clinical ef-
ficacy, safety, patient reported outcomes (i.e., HRQOL,
symptoms and treatment satisfaction), and costs of the
available treatment modalities in order to make in-
formed medical decisions and to optimize care of pa-
tients with varicose veins. Currently, at least four
RCT’s on the treatment of varicose veins are ‘ongoing’
(www.controlled-trials.com) and the preliminary re-
sults of meta-analysis suggest that EVLT is signifi-
cantly superior in achieving anatomical success
using ultrasound criteria compared to RFA, UGFS
and surgery (personal communication by RRVDB).
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